Skandinaviska Enskilda Banken Ab (Publ) Krystal Biotech, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$21.6 Billion
Q4 2024

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 89,047 shares of KRYS stock, worth $16.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

89,047

Previous 126,082 29.37%

Holding current value

$16.7 Million

Previous $22.9 Million 39.16%

% of portfolio

0.06%

Previous 0.11%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$156.64 - $199.61 $5.8 Million - $7.39 Million	-37,035 Reduced 29.37%	89,047 $14 Million
Q3 2024 Nov 07, 2024	SELL	$174.7 - $213.66 $11.4 Million - $14 Million	-65,433 Reduced 34.17%	126,082 $22.9 Million
Q2 2024 Aug 13, 2024	SELL	$153.12 - $183.64 $4.02 Million - $4.82 Million	-26,232 Reduced 12.05%	191,515 $35.2 Million
Q1 2024 May 13, 2024	SELL	$108.01 - $179.35 $2.84 Million - $4.72 Million	-26,314 Reduced 10.78%	217,747 $38.7 Million
Q3 2023 Nov 09, 2023	SELL	$108.51 - $130.22 $4.54 Million - $5.44 Million	-41,799 Reduced 14.62%	244,061 $28.3 Million
Q2 2023 Aug 07, 2023	SELL	$78.48 - $130.32 $12,399 - $20,590	-158 Reduced 0.06%	285,860 $33.6 Million
Q1 2023 May 11, 2023	SELL	$72.39 - $84.27 $110,249 - $128,343	-1,523 Reduced 0.53%	286,018 $22.9 Million
Q4 2022 Feb 08, 2023	SELL	$63.14 - $79.9 $635,756 - $804,513	-10,069 Reduced 3.38%	287,541 $22.8 Million
Q2 2022 Aug 10, 2022	BUY	$48.93 - $73.47 $4.35 Million - $6.53 Million	88,899 Added 42.59%	297,610 $19.5 Million
Q1 2022 May 11, 2022	SELL	$51.99 - $72.11 $5,978 - $8,292	-115 Reduced 0.06%	208,711 $13.9 Million
Q4 2021 Feb 10, 2022	BUY	$39.81 - $88.24 $3.02 Million - $6.69 Million	75,825 Added 57.01%	208,826 $14.7 Million
Q3 2021 Nov 10, 2021	BUY	$52.01 - $71.77 $348,935 - $481,504	6,709 Added 5.31%	133,001 $6.94 Million
Q2 2021 Aug 10, 2021	BUY	$62.14 - $81.82 $7 Million - $9.22 Million	112,671 Added 827.19%	126,292 $8.59 Million
Q1 2021 May 14, 2021	BUY	$59.42 - $85.46 $809,359 - $1.16 Million	13,621 New	13,621 $1.05 Million

Others Institutions Holding KRYS

# of Institutions

300

Shares Held

24.3M

Call Options Held

388K

Put Options Held

233K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.8B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Krystal Biotech, Inc. Transaction History